CUTIA-B: Next Day Disclosure Return
CUTIA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2024
CUTIA-B: VOLUNTARY ANNOUNCEMENT - RESULTS OF PHASE III CLINICAL TRIAL OFCU-40102 (TOPICAL FINASTERIDE SPRAY) IN THE PRCACCEPTED FOR E-POSTER PRESENTATION ATTHE 8TH ANNUAL MEETING OF CHINESE HAIR RESEARCH SOCIETY
CUTIA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
CUTIA-B: VOLUNTARY ANNOUNCEMENT - DRUG MARKETING AUTHORIZATION APPLICATION FOR CU-30101 (LOCALIZED TOPICAL LIDOCAINE AND TETRACAINE CREAM) ACCEPTED BY THE NATIONAL MEDICAL PRODUCTS ADMINISTRATION
CUTIA-B: VOLUNTARY ANNOUNCEMENT - RESULTS OF PHASE III CLINICAL TRIAL OF CU-10201 (TOPICAL 4% MINOCYCLINE FOAM) IN THE PRC PUBLISHED ONLINE IN THE JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
CUTIA-B: Next Day Disclosure Return
CUTIA-B: Next Day Disclosure Return
CUTIA-B: Next Day Disclosure Return
CUTIA-B: Next Day Disclosure Return
CUTIA-B: VOLUNTARY ANNOUNCEMENT - SHARE REPURCHASE PROGRAM UNDERTHE SHARE REPURCHASE MANDATE
CUTIA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
CUTIA-B: VOLUNTARY ANNOUNCEMENT - LAST PATIENT ENROLLED IN THE PHASE II CLINICAL TRIAL OF CU-20401 (RECOMBINANT MUTANT COLLAGENASE) FOR SUBMENTAL ADIPOSE ACCUMULATION
CUTIA-B: VOLUNTARY ANNOUNCEMENT - RESULTS OF PHASE III CLINICAL TRIAL OF CU-10201 (TOPICAL 4% MINOCYCLINE FOAM) IN THE PRC ACCEPTED FOR E-POSTER PRESENTATION AT THE 29TH ANNUAL MEETING OF CSD
CUTIA-B: OPERATIONAL UPDATE FORTHE FIRST QUARTER OF 2024
CUTIA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
CUTIA-B: VOLUNTARY ANNOUNCEMENT - RESULTS OF PHASE III CLINICAL TRIAL OFCU-10201 (TOPICAL 4% MINOCYCLINE FOAM) IN THE PRC PRESENTED AT THE 13TH ADC
CUTIA-B: VOLUNTARY ANNOUNCEMENT - INVESTIGATIONAL NEW DRUG APPLICATION OF CU-10101(TOPICAL NOVEL SMALL MOLECULE AGENT) FORATOPIC DERMATITIS APPROVED BY THE CENTER FOR DRUGEVALUATION OF THE NATIONAL MEDICALPRODUCTS ADMINISTRATION
CUTIA-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
CUTIA-B: VOLUNTARY ANNOUNCEMENT - SUBMISSION OF NEW DRUG APPLICATIONFOR CU-40102 (TOPICAL FINASTERIDE SPRAY)IN HONG KONG, PRC
No Data
No Data